KR101023696B1 - 신규 사이클릭 티오 유레아 유도체, 그의 제법 및 이를 함유한 미백용 조성물 - Google Patents
신규 사이클릭 티오 유레아 유도체, 그의 제법 및 이를 함유한 미백용 조성물 Download PDFInfo
- Publication number
- KR101023696B1 KR101023696B1 KR1020090053199A KR20090053199A KR101023696B1 KR 101023696 B1 KR101023696 B1 KR 101023696B1 KR 1020090053199 A KR1020090053199 A KR 1020090053199A KR 20090053199 A KR20090053199 A KR 20090053199A KR 101023696 B1 KR101023696 B1 KR 101023696B1
- Authority
- KR
- South Korea
- Prior art keywords
- thione
- tetrahydropyrimidine
- urea derivative
- cyclic
- imidazolidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
- C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
- C07D233/10—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
- 제 1 항에 있어서,상기 유도체는 1-벤질-테트라하이드로피리미딘-2-티온, 1-(4-메틸벤질)-테트라하이드로피리미딘-2-티온, 1-(4-에틸벤질)-테트라하이드로피리미딘-2-티온, 1-(4-t-부틸벤질)-테트라하이드로피리미딘-2-티온, 1-(4-클로로벤질)-테트라하이드로피리미딘-2-티온, 1-(4-메톡시벤질)-테트라하이드로피리미딘-2-티온, 1-(나프틸)-테트라하이드로피리미딘-2-티온, 1-(2-페닐에틸)-테트라하이드로피리미딘-2-티온, 1-(3-페닐프로필)-테트라하이드로피리미딘-2-티온, 1-벤질-이미다졸리딘-2-티온, 1-(4-메틸벤질)-이미다졸리딘-2-티온, 1-(4-클로로벤질)-이미다졸리딘-2-티온, 1-(4-메톡시벤질)-이미다졸리딘-2-티온, 1-(2-페닐에틸)-이미다졸리딘-2-티온 또는 1-(3-페닐프로필)-이미다졸리딘-2-티온인 것을 특징으로 하는 사이클릭 티오 유레아 유도체.
- 하기 반응식에 의해,(A) 다이아미노프로판(2)을 다이터셜리뷰틸 다이카보네이트와 반응하여 한쪽 아민기를 터셜리뷰틸카보네이트로 보호한 화합물(3)을 제조하는 단계;(B) 화합물(3)과 알데하이드(4)를 축합 반응한 후 환원하여 아민화합물(5)을 제조하는 단계;(C) 아민화합물(5)를 염기성 조건에서 반응시켜 보호기가 제거되고 고리화된 사이클릭 유레아 유도체(6)을 제조하는 단계;(D) 사이클릭 유레아 유도체(6)을 라외슨 시약과 반응하여 목적화합물 사이클릭 티오 유레아 유도체(1)를 제조하는 단계;를 포함하는 것을 특징으로 하는 제 1 항에 의한 사이클릭 티오 유레아 유도체(1)의 제조방법.[반응식]
- 제 1 항 또는 제 2 항에 의한 사이클릭 티오 유레아 유도체를 유효성분으로 함유하는 과색소침착 피부질환 예방 또는 치료용 조성물.
- 제 1 항 또는 제 2 항에 의한 사이클릭 티오 유레아 유도체를 유효성분으로 함유하는 미백용 화장료 조성물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080080686 | 2008-08-19 | ||
KR20080080686 | 2008-08-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20100022429A KR20100022429A (ko) | 2010-03-02 |
KR101023696B1 true KR101023696B1 (ko) | 2011-03-25 |
Family
ID=42174988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090053199A KR101023696B1 (ko) | 2008-08-19 | 2009-06-16 | 신규 사이클릭 티오 유레아 유도체, 그의 제법 및 이를 함유한 미백용 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101023696B1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014019644A (ja) * | 2012-07-12 | 2014-02-03 | Miki Riken Kogyo Kk | エチレン尿素の製造方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070058533A (ko) * | 2004-09-28 | 2007-06-08 | 알러간, 인코포레이티드 | 특이적인 또는 선택적인 알파2 아드레날린성아고니스트로서 작용하는 비치환된 및 치환된4-벤질-1,3-디히드로-이미다졸-2-티온 및 이를 사용하는방법 |
-
2009
- 2009-06-16 KR KR1020090053199A patent/KR101023696B1/ko active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070058533A (ko) * | 2004-09-28 | 2007-06-08 | 알러간, 인코포레이티드 | 특이적인 또는 선택적인 알파2 아드레날린성아고니스트로서 작용하는 비치환된 및 치환된4-벤질-1,3-디히드로-이미다졸-2-티온 및 이를 사용하는방법 |
Also Published As
Publication number | Publication date |
---|---|
KR20100022429A (ko) | 2010-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007052882A1 (en) | Pyridine thiazole carboxamide derivatives, the preparation method thereof, and the composition for skin whitening containing the same | |
JP2006306863A (ja) | メラニン生成抑制剤 | |
KR20110097576A (ko) | 벤즈알데하이드 티오세미카바존 유도체를 함유한 미백용 조성물 | |
KR101023696B1 (ko) | 신규 사이클릭 티오 유레아 유도체, 그의 제법 및 이를 함유한 미백용 조성물 | |
WO2018053706A1 (en) | Composition comprising paeoniflorin or albiflorin analogue, method of preparation thereof | |
KR101104307B1 (ko) | 신규 다이하이드로 퀴나졸린-2-싸이온 유도체 및 이를 함유한 미백용 조성물 | |
KR101246682B1 (ko) | 아릴티오우레아 유도체를 함유한 미백용 조성물 | |
KR100747042B1 (ko) | 신물질6-메틸-3-펜에틸-3,4-디히드로-1h-큐나졸린-2-티온,이의 제조방법 및 이를 유효성분으로 포함하는 미백 효능조성물 | |
KR101126818B1 (ko) | c-Kit 활성 저해제, 피부미백제 및 이를 함유하는피부미백용 조성물 | |
KR102092227B1 (ko) | 비스 페닐 헥사 트리엔 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 피부 미백용 조성물 | |
KR102075560B1 (ko) | 피부 미백용 조성물 | |
KR100963441B1 (ko) | 신물질 1,3-디하이드로벤즈이미다졸-2-싸이온 유도체, 그의제법 및 이를 유효성분으로 하는 미백용 화장료 조성물 | |
JP2013053159A (ja) | (2z,8z)―メトリカリア酸メチルエステルを有効成分として含む皮膚美白用組成物 | |
KR102146509B1 (ko) | 피부 미백용 조성물 | |
KR101216949B1 (ko) | 미백활성을 가지는 신규 코지산 유도체, 이의 제조방법 및 이를 포함하는 미백화장료 조성물 | |
KR20070099189A (ko) | 타이로시나아제 및 멜라닌 생성 저해 활성을 갖는 칼콘유도체 또는 이의 약학적으로 허용가능한 염을유효성분으로 함유하는 피부 미백용 조성물 | |
KR100630905B1 (ko) | 신규한 히드록시아닐린 유도체의 염을 포함하는 화장품조성물 | |
KR101488583B1 (ko) | 피부미백 활성을 갖는 신규 화합물 및 이의 의학적 용도 | |
KR102631500B1 (ko) | 헴프씨드박 추출물을 유효성분으로 함유하는 피부 미백용 조성물 | |
KR101449831B1 (ko) | 피부미백 활성을 갖는 신규 화합물 및 이의 의학적 용도 | |
KR100407640B1 (ko) | 신규한 디페닐 아미드 유도체, 그의 제조방법 및 이를포함하는 약학 및 화장료 조성물 | |
JP7315732B2 (ja) | ジメチルフェニルチオウレアを含む皮膚美白用組成物 | |
KR101520653B1 (ko) | 복합 비타민 컨쥬게이트 및 그를 포함하는 항산화제 | |
KR101154233B1 (ko) | 타이로신 유도체를 함유하는 미백용 화장료 조성물 | |
KR101149781B1 (ko) | 비스3,5?디메톡시칼콘을 포함하는 피부노화억제제 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20140228 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20150310 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20160315 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20170313 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20180219 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20190226 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20200224 Year of fee payment: 10 |